Hepatitis B Vaccine (Recombinant) Adjuvanted

FDA Drug Profile — HEPLISAV-B

Hepatitis B Vaccine (Recombinant) Adjuvanted is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including HEPLISAV-B. Available dosage form: injection, solution.

Drug details

Generic Name
Hepatitis B Vaccine (Recombinant) Adjuvanted
Brand Names
HEPLISAV-B
Application Number
BLA125428
Sponsor
Dynavax Technologies Corporation
NDC Codes
4
Dosage Forms
INJECTION, SOLUTION
Routes
INTRAMUSCULAR
Active Ingredients
HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.